Author

Sulin Wu

Observed name: S. Wu

Institutions: University of Chicago, University of Chicago Medical Center

Observed institutions: University Hospitals of Cleveland, University of Chicago, University of Chicago Medical Center, University Hospitals Cleveland Medical Center, University Hospitals Seidman Cancer Center, Hohhot First Hospital, Case Western Reserve University

ORCID: 0000-0002-9820-724X

Observed ORCID: 0000-0002-9820-724X

OpenAlex ID: A5082734112

Management of Appendix Neuroendocrine Neoplasms: Insights on the Current Guidelines

2022 · Amr Mohamed, Sulin Wu, et al. · Cancers · 50

Bridging Immune Evasion and Vascular Dynamics for Novel Therapeutic Frontiers in Hepatocellular Carcinoma

2025 · Sulin Wu, Namrata Anand, et al. · Cancers · 25

Tumor-Agnostic Therapies in Practice: Challenges, Innovations, and Future Perspectives

2025 · Sulin Wu, Rajat Thawani · Cancers · 24

Outcomes of Antineoplastic Immunotherapy at a Large Healthcare Organization: Impact of Provider, Race and Socioeconomic Status

2023 · Matthew M Mirsky, Carley Mitchell, et al. · Cancer Management and Research · 5

Regulation of antiviral and antitumor immunity by the BRCA1 pseudogene in human cancers

2026 · Yoo Jane Han, Jing Zhang, et al. · Proceedings of the National Academy of Sciences · 2

Video Education in Germline Genetic Testing: A Step Toward Improved Access to Personalized Medicine

2025 · Sulin Wu, Cara Essling, et al. · JCO Oncology Practice · 1

Racial Disparities in Thymic Epithelial Tumors: Insights from a Multiracial Urban Cohort

2026 · Erica Pietroluongo, Christine M. Bestvina, et al. · Clinical Lung Cancer

Severe Hyperammonemia and Coma in a Post-partum Patient Secondary to a Urea Cycle Disorder

2023 · S. Gupta, S. Wu, et al.

Works count: 9

Citation count: 107

H-index: 4

I10-index: 3